Advancements in Nanoemulsion-Based Drug Delivery Across Different Administration Routes
Pharmaceutics · 05.03.2025 · 17 (3) · 337
DOI: 10.3390/pharmaceutics17030337 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 05.03.2025. Verfasst von Maria D Chatzidaki und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council Proof-of-Concept (PoC) programme, Horizon Europe Programme under the “Widening Participation Spreading Excellence” component (call ERA Chairs “HORIZONWIDERA-2022-TALENTS-01-01–ERA Chairs”).
Abstract (Originalsprache)
Nanoemulsions (NEs) have emerged as effective drug delivery systems over the past few decades due to their multifaceted nature, offering advantages such as enhanced bioavailability, protection of encapsulated compounds, and low toxicity. In the present review, we focus on advancements in drug delivery over the last five years across (trans)dermal, oral, ocular, nasal, and intra-articular administration routes using NEs. Rational selection of components, surface functionalization, incorporation of permeation enhancers, and functionalization with targeting moieties are explored for each route discussed. Additionally, apart from NEs, we explore NE-based drug delivery systems (e.g., NE-based gels) while highlighting emerging approaches such as vaccination and theranostic applications. The growing interest in NEs for drug delivery purposes is reflected in clinical trials, which are also discussed. By summarizing the latest advances, exploring new strategies, and identifying critical challenges, this review focuses on developments for efficient NE-based therapeutic approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece.
- Institute for Bio-Innovation, Biomedical Sciences Research Center "Alexander Fleming", 16672 Vari, Greece.
- Department of Molecular Chemistry and Materials Science, Weizmann Institute of Science, 6100 Rehovot, Israel.
ORCID-Profile: Maria D Chatzidaki, Evgenia Mitsou
Förderung
- European Research Council Proof-of-Concept (PoC) programme
- Horizon Europe Programme under the “Widening Participation Spreading Excellence” component (call ERA Chairs “HORIZONWIDERA-2022-TALENTS-01-01–ERA Chairs”)
Zitieren
APA
Chatzidaki, M. D., & Mitsou, E. (2025). Advancements in Nanoemulsion-Based Drug Delivery Across Different Administration Routes. Pharmaceutics, 17(3), 337. https://doi.org/10.3390/pharmaceutics17030337
Vancouver
Chatzidaki MD, Mitsou E. Advancements in Nanoemulsion-Based Drug Delivery Across Different Administration Routes. Pharmaceutics. 2025;17(3):337. doi:10.3390/pharmaceutics17030337
BibTeX
@article{Chatzidaki2025,
author = {Chatzidaki, Maria D and Mitsou, Evgenia},
title = {Advancements in Nanoemulsion-Based Drug Delivery Across Different Administration Routes},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {3},
pages = {337},
doi = {10.3390/pharmaceutics17030337}
}
EUVIMED